Allakos (STU:37Z) Ending Cash Position : €18.36 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Allakos Ending Cash Position?

Allakos's Ending Cash Position for the quarter that ended in Dec. 2024 was €18.36 Mil.

Allakos's quarterly Ending Cash Position declined from Jun. 2024 (€25.98 Mil) to Sep. 2024 (€10.74 Mil) but then increased from Sep. 2024 (€10.74 Mil) to Dec. 2024 (€18.36 Mil).

Allakos's annual Ending Cash Position declined from Dec. 2022 (€83.72 Mil) to Dec. 2023 (€62.28 Mil) and declined from Dec. 2023 (€62.28 Mil) to Dec. 2024 (€18.36 Mil).

Allakos Ending Cash Position Historical Data

The historical data trend for Allakos's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allakos Ending Cash Position Chart

Allakos Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

172.17

137.26

83.72

62.28

18.36

Allakos Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															62.28	40.97	25.98	10.74	18.36

Allakos Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Allakos's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	64.856	+	-46.496
	=	18.36

Allakos's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.385	+	6.975
	=	18.36

Allakos Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Allakos's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Allakos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (STU:37Z) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ALLK:USA

Address

825 Industrial Road, Suite 500, San Carlos, CA, USA, 94070

Website

https://www.allakos.com

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation. Its portfolio consists of antibodies that target receptors, particularly Siglec-6, Siglec-8 and other anti-Siglec antibodies, including some antibodies in preclinical development.

Allakos Headlines

No Headlines